{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "19990816",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "19980227",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "41800",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20906.html",
              "date": "19980227",
              "type": "Review"
            },
            {
              "id": "26169",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20906_Etopophos_appltr_chemr.pdf",
              "date": "19980227",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20021105",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "3720",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20457slr006,20906slr002ltr.pdf",
              "date": "20021105",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA020906",
      "sponsor_name": "BRISTOL MYERS SQUIBB",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "ETOPOPHOS PRESERVATIVE FREE",
          "active_ingredients": [
            {
              "name": "ETOPOSIDE PHOSPHATE",
              "strength": "EQ 500MG BASE/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "ETOPOPHOS PRESERVATIVE FREE",
          "active_ingredients": [
            {
              "name": "ETOPOSIDE PHOSPHATE",
              "strength": "EQ 1GM BASE/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}